Cargando…
Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?
OBJECTIVES: The aim of the study was to explore the putative significance of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and its correlation with the lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: ACE I/D polymorphisms...
Autores principales: | Bid, Hemant Kumar, Manchanda, Parmeet Kaur, Konwar, Rituraj, Hanif, Kasif, Nayak, V. Laxman, Singh, Vishwajeet |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034055/ https://www.ncbi.nlm.nih.gov/pubmed/21369379 http://dx.doi.org/10.4103/0970-1591.74438 |
Ejemplares similares
-
Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia
por: Manchanda, Parmeet Kaur, et al.
Publicado: (2012) -
Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities
por: Manchanda, Parmeet Kaur, et al.
Publicado: (2012) -
Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007) -
Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016) -
Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)